Immunotherapy
-
Nanobody hitchhikers boost immunotherapy potency in cancer treatment
Researchers led by John T. Wilson, associate professor of chemical and biomolecular engineering and biomedical engineering, have developed a new approach using a molecularly designed nanobody platform that seeks to make immunotherapy more effective in the treatment of cancer. The research, “Potentiating Cancer Immunotherapies with Modular Albumin-Hitchhiking Nanobody-STING… Read MoreJun. 13, 2025
-
Ultrasound imaging of breast cancer tumors offers non-invasive monitoring of radiation and immunotherapy response effectiveness
Researchers led by John T. Wilson, associate professor of chemical and biomolecular engineering and biomedical engineering, have developed a new approach using a molecularly designed nanobody platform that seeks to make immunotherapy more effective in the treatment of cancer. The research, “Potentiating Cancer Immunotherapies with Modular Albumin-Hitchhiking Nanobody-STING… Read MoreJan. 28, 2025
-
Wilson awarded Komen breast cancer research grant
Researchers led by John T. Wilson, associate professor of chemical and biomolecular engineering and biomedical engineering, have developed a new approach using a molecularly designed nanobody platform that seeks to make immunotherapy more effective in the treatment of cancer. The research, “Potentiating Cancer Immunotherapies with Modular Albumin-Hitchhiking Nanobody-STING… Read MoreSep. 25, 2019
-
Wilson is ‘A’ Award grant recipient for neuroblastoma immunotherapy work
Researchers led by John T. Wilson, associate professor of chemical and biomolecular engineering and biomedical engineering, have developed a new approach using a molecularly designed nanobody platform that seeks to make immunotherapy more effective in the treatment of cancer. The research, “Potentiating Cancer Immunotherapies with Modular Albumin-Hitchhiking Nanobody-STING… Read MoreFeb. 17, 2016